Patient-reported Outcomes from JAVELIN Bladder 100: Avelumab First-line Maintenance Plus Best Supportive Care Versus Best Supportive Care Alone for Advanced Urothelial Carcinoma

EUROPEAN UROLOGY(2023)

引用 78|浏览15
摘要
To determine whether substance P induces the expression of adhesion molecules ICAM-1 and VCAM-1 on vascular endothelial cells, we examined the effect of substance P, its carboxyl- and amino-terminal peptides, and neurokinin A on the expression of ICAM-1 and VCAM-1 on cultured human umbilical vein endothelial cells (HUVEC). Substance P and the carboxyl-terminal peptide SP(6–11), but not the amino-terminal peptide SP(1–9) or neurokinin A, increased ICAM-1 expression on HUVEC. In contrast, substance P did not significantly induce VCAM-1 expression on HUVEC. Furthermore, stimulation of HUVEC with substance P increased neutrophil transendothelial migration through an ICAM-1-dependent mechanism, as indicated by the inhibitory effect of anti-ICAM-1 antibody. These results indicate that substance P induces ICAM-1 expression on vascular endothelial cells and thereby enhances neutrophil transendothelial migration.
更多
查看译文
关键词
Anti-PD-L1,Avelumab,Bladder cancer,Immune checkpoint inhibitor,Immunotherapy,Patient-reported outcomes,Quality of life,Urothelial carcinoma
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
0
您的评分 :

暂无评分

数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn